Is There a Relationship Between Hyperlipidemia and Periodontitis?

NCT ID: NCT02826720

Last Updated: 2016-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of present study is to investigate any relationship between hyperlipidemia and periodontal disease regarding the periodontal parameters and plasma lipid parameters, along with age, gender, brushing habit, body mass index, dietary habit, physical activity, alcohol consumption.

In this cross sectional study, a total of 160 individuals were divided into two groups based on their metabolic status: hyperlipidemic group (n=97) and normolipidemic group (n=63). Plaque index, gingival index, bleeding on probing (BOP), probing depth (PD), clinical attachment level (CAL) clinical parameters and community periodontal index of treatment needs (CPITN) scores were measured. Triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C) levels had been determined previously during individuals routine systemic examinations. Daily brushing habits and interdental cleaning together with dietary habits, alcohol consumption and physical activity levels were also recorded.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperlipidemia, Periodontal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HP+

Subjects with plasma Triglyceride or Total cholesterol levels \> 200 mg/dl and low density lipoprotein-cholesterol levels \> 130 mg/dl were included in the hyperlipidemic group and having periodontitis which were further evaluated for clinical periodontal parameters as well as to define the effects of the patient's habits on plasma lipid levels.

No intervention was applied

Intervention Type OTHER

No intervention was applied

HP-

Subjects with plasma Triglyceride or Total cholesterol levels \> 200 mg/dl and low density lipoprotein-cholesterol levels \> 130 mg/dl were included in the hyperlipidemic group and do not have periodontitis which were further evaluated for clinical periodontal parameters as well as to define the effects of the patient's habits on plasma lipid levels.

No intervention was applied

Intervention Type OTHER

No intervention was applied

NP+

Subjects with plasma Triglyceride or Total cholesterol levels \< 200 mg/dl and low density lipoprotein-cholesterol levels \< 130 mg/dl were included in the normolipidemic group and having periodontitis which were further evaluated for clinical periodontal parameters as well as to define the effects of the patient's habits on plasma lipid levels.

No intervention was applied

Intervention Type OTHER

No intervention was applied

NP-

Subjects with plasma Triglyceride or Total cholesterol levels \< 200 mg/dl and low density lipoprotein-cholesterol levels \< 130 mg/dl were included in the normolipidemic group and do not have periodontitis which were further evaluated for clinical periodontal parameters as well as to define the effects of the patient's habits on plasma lipid levels.

No intervention was applied

Intervention Type OTHER

No intervention was applied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention was applied

No intervention was applied

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects having no periodontal treatment within previous 6 months,
* number of natural teeth ≥ 10,
* no history of cancer and systemic disease that affects lipid levels or periodontium,
* no history of medical treatment for hyperlipidemia, BMI\< 30 kg/m2,
* no pregnancy,
* no history of systemic antibiotic treatment within previous 3 months,
* no smoking.

Exclusion Criteria

* patients with history of systemic disease that affects lipid metabolism or periodontal disease
* history of medical treatment for hyperlipidemia
* pregnancy, lactation or hormone replacement therapy at the time of study
* use of any other drug known to affect lipid metabolism or periodontal disease
* systemic infection or any history of systemic antibiotic treatment in previous 3 months
* smokers as well as ex-smokers
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marmara University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gülin Tulu Katı, PhD

Role: PRINCIPAL_INVESTIGATOR

Periodontist in Private Practice., Istanbul, Turkey. (E-mail: [email protected])

Ülkü Noyan, Prof. Dr.

Role: STUDY_CHAIR

Periodontist in Private Practice., Istanbul, Turkey. (E-mail: [email protected])

Bahar Kuru, Prof. Dr.

Role: STUDY_CHAIR

Department of Periodontology, Faculty of Dentistry, Yeditepe University, Istanbul, Turkey. (E-mail: [email protected])

Leyla Kuru, Prof. Dr.

Role: STUDY_DIRECTOR

Department of Periodontology, Faculty of Dentistry, Marmara University, Istanbul, Turkey. (E-mail: [email protected])

Ömer Birkan Ağralı, PhD

Role: STUDY_CHAIR

Department of Periodontology, Faculty of Dentistry, Marmara University, Istanbul, Turkey. ([email protected])

Hatice Selin Yıldırım, PhD

Role: STUDY_CHAIR

Department of Periodontology, Faculty of Dentistry, Marmara University, Istanbul, Turkey. (Email: [email protected])

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MIHS-25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.